Alzheon Announces Closing Of Oversubscribed $50 Million Series D Financing Round To Accelerate Completion Of Apolloe4 Phase 3 Trial And Expansion Of Product Portfolio
Amount Raised
$50 Million
Round Type
Series D
FraminghamBiotechnologyDescription
Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from Alzheimer’s disease (AD) and other neurodegenerative disorders, today announced that it has completed an oversubscribed $50 million Series D round from private and institutional investors.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Alzheon that raised within 45 days of this round, from Fundz verified event records.
- Elicio Therapeutics raised $975K (Series B) on May 27, 2022.
- Celularity raised $30M on May 27, 2022.
- Pictor Labs raised $7.6M on May 27, 2022.
- Cerillo, Inc. raised $875K (Seed) on May 27, 2022.
- Aurora Cannabis raised $125M (Funding Round) on May 26, 2022.
- Mazen Animal Health Inc. raised $11M on May 26, 2022.
Who to call at Alzheon, and when
A new round usually means Alzheon is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Alzheon raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alzheon, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alzheon. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alzheon raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Alzheon raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.